Recent research highlights the complexities surrounding the regulation of manufactured multicomponent nanomaterials (MCNMs) under the European chemicals’ regulation REACH. Although most of these materials are covered by REACH and its nano-specific updates, uncertainties remain regarding their categorisation and assessment. More precise definitions and guidelines are needed to ensure safe and sustainable management of these advanced materials as technology evolves.

Researchers have developed an Adverse Outcome Pathway (AOP) that describes how nanomaterials (NMs) can compromise the gut’s protective barrier, leading to a “leaky gut”. The AOP outlines the biological mechanisms through which ingested NMs can harm intestinal integrity and increase permeability. Despite existing uncertainties and knowledge gaps, the AOP and associated testing methods are relevant for the risk assessment of NMs.

Recent advancements in recycling technologies for carbon nanotubes and epoxy resins show promise in enhancing their sustainability and reusability. By focusing on innovative bonding techniques, researchers are tackling the complex challenges associated with recycling these strong materials, paving the way for a more efficient circular economy.

The EU Innovation Network of regulators has released a Horizon Scanning Report on Nanomedicines, highlighting key trends, challenges and recommendations for regulatory collaboration. It emphasises the growing applications of nanotechnology in medicine and the need for improved regulatory frameworks. A new platform for regulatory science research is set to launch in 2025, aimed at enhancing dialogue between researchers and regulators. This call for regulatory preparedness aligns with similar recommendations and initiatives in the field of nanomaterials.

The UK government hosted two workshops to promote collaboration on the safe and sustainable development of advanced materials. These events brought together diverse stakeholders to share insights and shape relevant policies. Attendees highlighted the need for regulatory definitions, standards and test methods, and incentives to stimulate safe and sustainable development (SSbD) of advanced materials. In particular, there was a call for training small and medium enterprises (SMEs) on the SSbD concept and tools available for implementation. In addition, RIVM identified a need for improved integration of sustainability aspects like durability, reusability, and recyclability into SSbD approaches.

Several OECD guidelines for testing chemicals have been updated to include nanospecific considerations, which are generally effective. Despite these efforts, challenges remain in standardising the testing of nanomaterials in water, as particles tend to clump together, leading to unstable dispersions and irreproducible results.

Nanoforms of fertilisers or biostimulants sprayed directly onto plant leaves may contribute to more sustainable agricultural practices. However, it needs to be clarified whether the current legislation and methodologies sufficiently addresses the nanospecific properties of these products when assessing the benefits and risks for crops, the environment, and human health.

Two recent reports reviewed existing New Approach Methodologies (NAMs). One focussed on the purpose of regulatory risk assessment and the other on in silico methods for the Safe-and-Sustainable-by-Design (SSbD) of nanomaterials.

The European Scientific Committee on Consumer Safety (SCCS) evaluated information on genotoxicity of titanium dioxide used in cosmetic products. This was triggered by previous similar concerns for food additive E 171 (titanium dioxide, TiO2).

The past few decades of managing the uncertain risks for human and environment associated with nanomaterials have provided crucial insights for ensuring the safe and sustainable development of advanced materials.